These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of cyclooxygenase inhibition on the pulmonary vasodilator response to furosemide. Lundergan CF; Fitzpatrick TM; Rose JC; Ramwell PW; Kot PA J Pharmacol Exp Ther; 1988 Jul; 246(1):102-6. PubMed ID: 3134540 [TBL] [Abstract][Full Text] [Related]
6. Comparative effects of thromboxane B2 on the canine and feline pulmonary vascular bed. Kadowitz PJ; Hyman AL J Pharmacol Exp Ther; 1980 May; 213(2):300-5. PubMed ID: 7365689 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of prostaglandins A, E, F, and B on the canine pulmonary vascular bed. Kadowitz PJ; Joiner PD; Greenberg S; Hyman AL Adv Prostaglandin Thromboxane Res; 1976; 1():403-15. PubMed ID: 998434 [TBL] [Abstract][Full Text] [Related]
9. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids. Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056 [TBL] [Abstract][Full Text] [Related]
10. Action and metabolism of prostaglandins in the pulmonary circulation. Kadowitz PJ; Lippton HL; McNamara DB; Spannhake EW; Hyman AL Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():333-56. PubMed ID: 6216787 [No Abstract] [Full Text] [Related]
11. Arachidonic acid responses in the lung. Kadowitz PJ; McNamara DB; She HS; Spannhake EW; Hyman AL Bull Eur Physiopathol Respir; 1981; 17(4):659-73. PubMed ID: 6799028 [No Abstract] [Full Text] [Related]
12. Effect of lung transit on systemic depressor responses to arachidonic acid and prostacyclin in dogs. Waldman HM; Alter I; Kot PA; Rose JC; Ramwell PW J Pharmacol Exp Ther; 1978 Feb; 204(2):289-93. PubMed ID: 340641 [TBL] [Abstract][Full Text] [Related]
13. Effects of prostaglandin H2 on perinatal pulmonary circulation. Tod ML; Cassin S; McNamara DB; Kadowitz PJ Pediatr Res; 1986 Jun; 20(6):565-9. PubMed ID: 3714368 [TBL] [Abstract][Full Text] [Related]
14. Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog. Dusting GJ; Moncada S; Vane JR Eur J Pharmacol; 1978 May; 49(1):65-72. PubMed ID: 350595 [TBL] [Abstract][Full Text] [Related]
15. Effects of adenosine triphosphate and prostaglandins on vascular adrenergic transmission. Su C; Tsuru H; Su MO J Pharmacol Exp Ther; 1978 Oct; 207(1):34-9. PubMed ID: 212549 [TBL] [Abstract][Full Text] [Related]
16. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164. Allan G; Levi R J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659 [TBL] [Abstract][Full Text] [Related]
17. Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin. Schrör K; Moncada S; Ubatuba FB; Vane JR Eur J Pharmacol; 1978 Jan; 47(1):103-14. PubMed ID: 338313 [TBL] [Abstract][Full Text] [Related]
18. Effect of prostaglandins on pancreatic circulation in anesthetized dogs. Homma T; Malik KU J Pharmacol Exp Ther; 1982 Sep; 222(3):623-8. PubMed ID: 7050343 [TBL] [Abstract][Full Text] [Related]
19. Pharmacology of prostaglandins in the pulmonary microcirculation. Ogletree ML Ann N Y Acad Sci; 1982; 384():191-206. PubMed ID: 7046563 [TBL] [Abstract][Full Text] [Related]
20. Endothelium-dependent and independent responses to prostaglandin H2 and arachidonic acid in isolated dog cerebral arteries. Toda N; Inoue S; Bian K; Okamura T J Pharmacol Exp Ther; 1988 Jan; 244(1):297-302. PubMed ID: 3121847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]